The FoundationOne CDx (F1CDx) cancer biomarker detection method was approved by the FDA in November 2017 to detect 324 different genes that can identify viable mutations in 5 tumor types including ...
genetic-testing
Breast cancer problemBreast cancer is a common female malignant tumor that seriously threatens the physical and mental health of women, so it is also known as the "red killer". Statistics show that b...
genetic-testing
Breast cancer & chemotherapyAmong the many cancers, breast cancer is probably the most difficult to decide whether to undergo chemotherapy after surgery. Similar to other cancers, the factors tha...
genetic-testing
British scientists begin genetic testing of childhood tumors. British scientists hope that genetic testing will give younger patients newer and more personalized treatments that will increase their s...
genetic-testing